Добірка наукової літератури з теми "Clec9A"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Clec9A".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Clec9A"
Caminschi, Irina, Anna I. Proietto, Fatma Ahmet, Susie Kitsoulis, Joo Shin Teh, Jennifer C. Y. Lo, Alexandra Rizzitelli, et al. "The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement." Blood 112, no. 8 (October 15, 2008): 3264–73. http://dx.doi.org/10.1182/blood-2008-05-155176.
Повний текст джерелаSchreibelt, Gerty, Lieke J. J. Klinkenberg, Luis J. Cruz, Paul J. Tacken, Jurjen Tel, Martin Kreutz, Gosse J. Adema, Gordon D. Brown, Carl G. Figdor, and I. Jolanda M. de Vries. "The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells." Blood 119, no. 10 (March 8, 2012): 2284–92. http://dx.doi.org/10.1182/blood-2011-08-373944.
Повний текст джерелаIto, Fumito, Mark D. Long, Ryutaro Kajihara, Satoko Matsueda, Takaaki Oba, Kazunori Kanehira, Song Liu, and Kenichi Makino. "Notch signaling is required for generation of conventional type 1 dendritic cells from human induced pluripotent stem cells." Journal of Immunology 208, no. 1_Supplement (May 1, 2022): 47.07. http://dx.doi.org/10.4049/jimmunol.208.supp.47.07.
Повний текст джерелаMasterman, Kelly-Anne, Oscar L. Haigh, Kirsteen M. Tullett, Ingrid M. Leal-Rojas, Carina Walpole, Frances E. Pearson, Jonathon Cebon, et al. "Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells." Journal for ImmunoTherapy of Cancer 8, no. 2 (July 2020): e000691. http://dx.doi.org/10.1136/jitc-2020-000691.
Повний текст джерелаBell, Elaine. "CLEC9A: linking necrosis and immunity." Nature Reviews Immunology 9, no. 4 (April 2009): 223. http://dx.doi.org/10.1038/nri2531.
Повний текст джерелаMasterman, Kelly-Anne, Oscar Haigh, Kirsteen Tullett, Ingrid Leal-Rojas, Carina Walpole, Frances Pearson, Jonathon Cebon, et al. "612 Human CLEC9A antibodies deliver NY-ESO-1 antigen to CD141+ dendritic cells to activate naïve and memory NY-ESO-1-specific CD8+ T cells." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A648. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0612.
Повний текст джерелаHaddad, Y., L. Laurans, S. Metghalchi, Z. Zeboudj, A. Giraud, Z. Mallat, and S. Taleb. "The role of CLEC9a in atherosclerosis development." Archives of Cardiovascular Diseases Supplements 9, no. 2 (April 2017): 184. http://dx.doi.org/10.1016/s1878-6480(17)30455-x.
Повний текст джерелаvan der Aa, Evelyn, Nadine van Montfoort, and Andrea M. Woltman. "BDCA3+CLEC9A+ human dendritic cell function and development." Seminars in Cell & Developmental Biology 41 (May 2015): 39–48. http://dx.doi.org/10.1016/j.semcdb.2014.05.016.
Повний текст джерелаPark, Hae-Young, Amanda Light, Mireille H. Lahoud, Irina Caminschi, David M. Tarlinton, and Ken Shortman. "Evolution of B Cell Responses to Clec9A-Targeted Antigen." Journal of Immunology 191, no. 10 (October 11, 2013): 4919–25. http://dx.doi.org/10.4049/jimmunol.1301947.
Повний текст джерелаShen, Lianjun, Janice BelleIsle, and Kenneth Rock. "Regulation of cross priming and anti-tumor immunity in vivo (107.2)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 107.2. http://dx.doi.org/10.4049/jimmunol.188.supp.107.2.
Повний текст джерелаДисертації з теми "Clec9A"
Haddad, Yacine. "Rôle de Clec9a dans l'athérosclérose." Thesis, Sorbonne Paris Cité, 2017. http://www.theses.fr/2017USPCB099/document.
Повний текст джерелаAtherosclerosis is a chronic inflammatory disease. One of the characteristics of atherosclerotic lesions is the abnormal accumulation of apoptotic and necrotic cells, due to a deficiency of efferocytosis, which leads to the formation of the necrotic heart. The evolution of this necrotic core is also associated with an increase in inflammation and lesions of atherosclerosis, but also in the occurrence of complications such as plaque rupture. Clec9a is a C type lectin receptor, mainly expressed by a subpopulation of dendritic cells, which are the CD8α+ dendritic cells. This receptor is able to recognize a ligand expressed by necrotic cells, the actin F. The aim of our work was to find out if Clec9a, which can sense necrotic cells, could be involved in modulating the inflammation observed during the development of atherosclerosis. In this study, we have shown, in vivo with two mouse models (ApoE - / - and LDLr - / -), that the deletion of Clec9a leads to a significant decrease in the incidence of moderate hypercholesterolemia. This athero-protection observed in the absence of Clec9a, is associated with an increase in the expression of IL-10, which is an anti-atherogenic and anti-inflammatory cytokine. This athero-protective effect of the absence of Clec9a is abolished after total invalidation of IL-10. Furthermore, we report that specific knockdown of Clec9a in CD8α+-DC, in vivo, leads to a decrease in macrophage and lymphocyte infiltration in lesions, as well as an increase in IL-1 expression. 10, which promotes a decrease in lesions size. Understanding of inflammatory mechanisms in atherosclerosis is a major challenge to prevent the risk of complications such as plaque rupture or thrombosis. Thus, this work highlights a new role of Clec9a in the regulation of inflammation in atherosclerosis and could be therefore a potential therapeutic target
Huysamen, Cristal. "The characterization of a novel C-type lectin-like receptor, CLEC9A." Doctoral thesis, University of Cape Town, 2008. http://hdl.handle.net/11427/3060.
Повний текст джерелаMesserer, Denise [Verfasser], and Sven [Akademischer Betreuer] Reese. "Bedeutung Clec9a-abhängiger Immunzellen in kardialen Entzündungsprozessen / Denise Messerer ; Betreuer: Sven Reese." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2020. http://d-nb.info/1215499965/34.
Повний текст джерелаVan, Blijswijk J. M. "Mouse models to deplete or label dendritic cells via genetic manipulation of the Clec9a locus." Thesis, University College London (University of London), 2015. http://discovery.ucl.ac.uk/1472681/.
Повний текст джерелаKöhler, Arnaud. "Rôle des cellules dendritiques pre-CD8α Clec9A+ dans la protection contre Listeria monocytogenes en début de vie". Doctoral thesis, Universite Libre de Bruxelles, 2016. http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/235619.
Повний текст джерелаDoctorat en Sciences biomédicales et pharmaceutiques (Médecine)
info:eu-repo/semantics/nonPublished
Lodhia, Puja. "Investigating the intracellular interactions of CLEC14A and the characterisation of monoclonal antibodies targeting CLEC14A." Thesis, University of Birmingham, 2016. http://etheses.bham.ac.uk//id/eprint/7014/.
Повний текст джерелаTeng, Ooiean, and 丁瑋嫣. "Identification of CLEC5A in modulating host immune response after influenza A virus infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2014. http://hdl.handle.net/10722/208615.
Повний текст джерелаpublished_or_final_version
Public Health
Doctoral
Doctor of Philosophy
Gonçalves, Maia Maria João. "Le syndrome Xeroderma Pigmentosum : Un nouveau modèle pour l’étude du rôle des fibroblastes dans la modulation de la réponse immunitaire innée contre les cellules cutanées cancéreuses." Electronic Thesis or Diss., Université Côte d'Azur (ComUE), 2019. http://www.theses.fr/2019AZUR4037.
Повний текст джерелаSkin cancer etiology is related to genetic mutations arising after ultraviolet (UV) sun exposure. The propagation of cancer cells is also dependent of a crosstalk with cells present in the surrounding microenvironment, mainly cancer associated fibroblasts (CAF) and immune cells. Xeroderma pigmentosum (XP) is a genetic disease that comprises seven groups of genetic complementation (XP-A to XP-G). XP patients present a default in the mechanism responsible for the repair of UV-induced DNA lesions. They are prone to develop skin cancers with high frequencies early in their life. XP-C is the most represented complementation group in Europe and in XP-C patients squamous cell carcinoma (SCC) are more frequent than basal cell carcinoma (BCC) (ratio 5:1). SCC have high metastatic potential compared to BCC. Previous studies suggested that the immune responses in XP patients could be altered with defects in their NK lytic activity and a decrease in the levels of circulating T lymphocytes. The main objective of this thesis was to identify microenvironment factors that could contribute to the progression of aggressive skin cancers using XP-C disease cells as a model of skin cancer susceptibility. Comparative transcriptomic analysis of WT and XP-C dermal patient’s fibroblasts revealed that CLEC2A, a ligand of the activating NK receptor NKp65 implicated in the activation of the innate immune system, is expressed in WT fibroblasts and absent in XP-C fibroblasts. Additional work showed that CLEC2A level is decreased in WT fibroblasts during replicative senescence, is absent in CAF and SCC, and is down regulated by soluble factors secreted by SCC cells. These results suggest that the loss of CLEC2A may induce a deficit of NK cell activation in the tumor microenvironment of SCC and in the dermis of XP-C patients. Elaboration of 3D skin culture models including NK cells and, in the presence or absence of blocking anti-CLEC2A antibody, allowed us to show that CLEC2A/NKp65 interaction regulates SCC cells invasion through a crosstalk between fibroblasts and NK cells. Our results suggest that the expression of CLEC2A in fibroblasts contributes to skin immune surveillance while, conversely, its absence under yet unidentified factors, favors the development of aggressive cancers in XP-C patients. CLEC2A could be a potential target in the fight against SCC progression
Medina, Mendieta Clelia [Verfasser]. "Business-to-Consumer eCommerce Adoption in Nicaragua / Clelia Medina Mendieta." Berlin : Freie Universität Berlin, 2018. http://d-nb.info/1170814581/34.
Повний текст джерелаKhan, Kabir Ali. "Investigating the extracellular interactions of the tumour endothelial marker CLEC14A." Thesis, University of Birmingham, 2016. http://etheses.bham.ac.uk//id/eprint/6909/.
Повний текст джерелаКниги з теми "Clec9A"
Berti, Paolo. Santa Clelia Barbieri. Milano: Edizioni paoline, 1991.
Знайти повний текст джерелаBassini, Remo. Dicono di Clelia. Milano: Mursia, 2006.
Знайти повний текст джерелаEbenezer, Lyn. Clecs Cwmderi. Caerydd: Hughes a'i Fab, 1986.
Знайти повний текст джерелаPodestá, Clelia. Mi nombre es Clelia. [Santiago de Chile: Editorial Los Heroes, 1996.
Знайти повний текст джерелаBoston, Credit Suisse First. Telecom services: CLECS. London: Credit Suisse First Boston, 2000.
Знайти повний текст джерелаDurrell, Lawrence. Clea. Thorndike, Me: G.K. Hall & Co., 2000.
Знайти повний текст джерелаLawrence, Durrell. Clea. New York: Penguin Books, 1991.
Знайти повний текст джерелаClelia Farnese: La figlia del Gran Cardinale. Viterbo: Sette città, 2010.
Знайти повний текст джерелаVatteroni, Sergio. Falsa clercia: La poesia anticlericale dei trovatori. Alessandria: Edizioni dell'Orso, 1999.
Знайти повний текст джерелаVatteroni, Sergio. Falsa clercia: La poesia anticlericale dei trovatori. Alessandria: Edizioni dell'Orso, 1999.
Знайти повний текст джерелаЧастини книг з теми "Clec9A"
Tetlak, Piotr, and Christiane Ruedl. "Analysis of Dendritic Cell Function Using Clec9A-DTR Transgenic Mice." In Methods in Molecular Biology, 275–89. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3606-9_20.
Повний текст джерелаReschen, Michael E., and Christopher A. O’Callaghan. "CLEC5A." In Encyclopedia of Signaling Molecules, 1147–54. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_572.
Повний текст джерелаWillment, Janet A., and Gordon D. Brown. "CLEC7A." In Encyclopedia of Signaling Molecules, 1154–61. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_584.
Повний текст джерелаReschen, Michael, and Christopher A. O’Callaghan. "CLEC5A." In Encyclopedia of Signaling Molecules, 1–8. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6438-9_572-1.
Повний текст джерелаvan Roy, Frans, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, et al. "Clec1a." In Encyclopedia of Signaling Molecules, 412. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_100278.
Повний текст джерелаvan Roy, Frans, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, et al. "CLEC5A." In Encyclopedia of Signaling Molecules, 421–25. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_572.
Повний текст джерелаvan Roy, Frans, Volker Nimmrich, Anton Bespalov, Achim Möller, Hiromitsu Hara, Jacob P. Turowec, Nicole A. St. Denis, et al. "CLEC7A." In Encyclopedia of Signaling Molecules, 425–31. New York, NY: Springer New York, 2012. http://dx.doi.org/10.1007/978-1-4419-0461-4_584.
Повний текст джерелаReschen, Michael E., Anita R. Mistry, and Christopher A. O’Callaghan. "CLEC4E." In Encyclopedia of Signaling Molecules, 1138–47. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_571.
Повний текст джерелаReschen, Michael E., Anita R. Mistry, and Christopher A. O’Callaghan. "CLEC4E." In Encyclopedia of Signaling Molecules, 1–9. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6438-9_571-1.
Повний текст джерелаKnudsen, Lars R. "CLEFIA." In Encyclopedia of Cryptography and Security, 210–11. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4419-5906-5_561.
Повний текст джерелаТези доповідей конференцій з теми "Clec9A"
Radford, Kristen, Frances Pearson, Kelly-Anne Masterman, Kirsteen Tullett, Oscar Haigh, Carina Walpole, Ghazal Daraj, Ingrid Leal Rojas, and Mireille Lahoud. "Abstract B125: Targeting human CD141+ DC using CLEC9A antibodies for cancer immunotherapy." In Abstracts: Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival; September 30 - October 3, 2018; New York, NY. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr18-b125.
Повний текст джерелаEtemad, M., G. Rink, C. Gerhards, and P. Bugert. "Correlation of CLEC1B Gene Polymorphisms with Plasma Levels of Soluble CLEC-2 in Healthy Individuals." In 63rd Annual Meeting of the Society of Thrombosis and Haemostasis Research. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1680198.
Повний текст джерелаAhmadi, Siavash, Mahshid Delavar, Javad Mohajeri, and Mohammad Reza Aref. "Security analysis of CLEFIA-128." In 2014 11th International ISC Conference on Information Security and Cryptology (ISCISC). IEEE, 2014. http://dx.doi.org/10.1109/iscisc.2014.6994027.
Повний текст джерелаProenca, Paulo, and Ricardo Chaves. "Compact CLEFIA Implementation on FPGAS." In 2011 International Conference on Field Programmable Logic and Applications (FPL). IEEE, 2011. http://dx.doi.org/10.1109/fpl.2011.101.
Повний текст джерелаMachado, Thiago, Alanna Santos, Tamiris Barros, Patrícia Oliveira, and Ana Bom. "High CLEC5A expression on monocytes is related with severe COVID-19." In International Symposium on Immunobiologicals. Instituto de Tecnologia em Imunobiológicos, 2022. http://dx.doi.org/10.35259/isi.2022_52201.
Повний текст джерелаTakahashi, Junko, and Toshinori Fukunaga. "Improved Differential Fault Analysis on CLEFIA." In 2008 5th Workshop on Fault Diagnosis and Tolerance in Cryptography (FDTC). IEEE, 2008. http://dx.doi.org/10.1109/fdtc.2008.14.
Повний текст джерелаAli, Sk Subidh, and Debdeep Mukhopadhyay. "Improved Differential Fault Analysis of CLEFIA." In 2013 Workshop on Fault Diagnosis and Tolerance in Cryptography (FDTC). IEEE, 2013. http://dx.doi.org/10.1109/fdtc.2013.11.
Повний текст джерелаBittencourt, Joao Carlos, Joao Carlos Resende, Wagner Luiz de Oliveira, and Ricardo Chaves. "CLEFIA Implementation with Full Key Expansion." In 2015 Euromicro Conference on Digital System Design (DSD). IEEE, 2015. http://dx.doi.org/10.1109/dsd.2015.55.
Повний текст джерелаTsunoo, Yukiyasu, Etsuko Tsujihara, Maki Shigeri, Tomoyasu Suzaki, and Takeshi Kawabata. "Cryptanalysis of CLEFIA using multiple impossible differentials." In 2008 International Symposium on Information Theory and Its Applications (ISITA). IEEE, 2008. http://dx.doi.org/10.1109/isita.2008.4895639.
Повний текст джерелаCheltha C., Jeba Nega, Rajan Kumar Jha, Mohit Jain, and Prahlad Kumar Sharma. "Contemporary Encryption Technique for Images using CLEFIA." In 2018 Second International Conference on Computing Methodologies and Communication (ICCMC). IEEE, 2018. http://dx.doi.org/10.1109/iccmc.2018.8488153.
Повний текст джерелаЗвіти організацій з теми "Clec9A"
Katagi, M., and S. Moriai. The 128-Bit Blockcipher CLEFIA. RFC Editor, March 2011. http://dx.doi.org/10.17487/rfc6114.
Повний текст джерелаFish, Jim. Overture to CLEA : the closed loop efficiency analysis project. Office of Scientific and Technical Information (OSTI), April 1985. http://dx.doi.org/10.2172/1574617.
Повний текст джерелаHawn, D., and J. Fish. CLEA: the Closed Loop Efficiency Analysis Facility for thermochemical energy transport studies. Office of Scientific and Technical Information (OSTI), May 1986. http://dx.doi.org/10.2172/5712175.
Повний текст джерела